Literature DB >> 8883119

Ultrasound parameters in osteoporotic patients treated with salmon calcitonin: a longitudinal study.

S Gonnelli1, C Cepollaro, C Pondrelli, S Martini, S Rossi, C Gennari.   

Abstract

Speed of sound (SOS) and broadband ultrasound attenuation (BUA) of ultrasound (US) in bone have been proposed as alternatives to radiation-based methods for the quantitative assessment of osteoporosis. However, the usefulness of US in monitoring response to treatment in osteoporotic patients has yet to be defined. To compare US with bone mineral density (BMD), we studied 112 osteoporotic women (age range 50-64 years). Seventy-eight of them were treated with salmon calcitonin nasal spray (CT; 200 IU/day, 1 month on and 1 month off) and calcium (500 mg/day); 34 patients were given only calcium. One hundred and four women complied with treatment throughout the 2-year study period. At baseline and after 1 and 2 years we measured BMD at lumbar spine by dual-energy X-ray absorptiometry (DXA), and SOS, BUA and Stiffness index, by an Achilles ultrasound unit. Moreover, biochemical markers of bone turnover (alkaline phosphatase, osteocalcin and hydroxyproline) were also measured at baseline and after 6, 12 and 24 months. In the calcitonin-treated group at the end of the study period BMD had increased by 1.99%, SOS by 0.20%, BUA by 0.88% and Stiffness by 2.12%. By contrast in the calcium-treated group all parameters had decreased (BMD, -2.66%; SOS, -0.55%; BUA, -3.30%; Stiffness, -6.0%) by the end of the study period. The differences between groups were significant for BMD, SOS and Stiffness. At baseline a significant, but weak correlation was found between BMD and US parameters. The correlation coefficients between percentage changes at the end of the study period, in BMD and in SOS, BUA and Stiffness, were all significant (p < 0.001), being 0.41, 0.53 and 0.57 respectively. In conclusion, ultrasound measurements carried out in conjunction with BMD measurements will yield a more comprehensive assessment of skeletal status and may be helpful in monitoring the response to treatment in osteoporotic patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8883119     DOI: 10.1007/bf01623389

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  32 in total

1.  Ultrasound attenuation of the calcaneus: a sensitive and specific discriminator of osteopenia in postmenopausal women.

Authors:  M Agren; A Karellas; D Leahey; S Marks; D Baran
Journal:  Calcif Tissue Int       Date:  1991-04       Impact factor: 4.333

2.  Salmon calcitonin reduces vertebral fracture rate in postmenopausal crush fracture syndrome.

Authors:  H Rico; E R Hernandez; M Revilla; F Gómez-Castresana
Journal:  Bone Miner       Date:  1992-02

3.  Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled double-blind clinical study.

Authors:  G F Mazzuoli; M Passeri; C Gennari; S Minisola; R Antonelli; C Valtorta; E Palummeri; G F Cervellin; S Gonnelli; G Francini
Journal:  Calcif Tissue Int       Date:  1986-01       Impact factor: 4.333

4.  Ultrasound measurements on os calcis: precision and age-related changes in a normal female population.

Authors:  A M Schott; D Hans; E Sornay-Rendu; P D Delmas; P J Meunier
Journal:  Osteoporos Int       Date:  1993-09       Impact factor: 4.507

Review 5.  Osteoporosis: recent advances in pathogenesis and treatment.

Authors:  C Cooper; A Aihie
Journal:  Q J Med       Date:  1994-04

6.  Quantitative ultrasound of the heel: correlation with densitometric measurements at different skeletal sites.

Authors:  K G Faulkner; M R McClung; L J Coleman; E Kingston-Sandahl
Journal:  Osteoporos Int       Date:  1994-01       Impact factor: 4.507

7.  Implications of architecture for the pathogenesis and prevention of vertebral fracture.

Authors:  A M Parfitt
Journal:  Bone       Date:  1992       Impact factor: 4.398

8.  Ultrasound discriminates patients with hip fracture equally well as dual energy X-ray absorptiometry and independently of bone mineral density.

Authors:  A M Schott; S Weill-Engerer; D Hans; F Duboeuf; P D Delmas; P J Meunier
Journal:  J Bone Miner Res       Date:  1995-02       Impact factor: 6.741

9.  Total and regional bone mineral content and fracture rate in postmenopausal osteoporosis treated with salmon calcitonin: a prospective study.

Authors:  H Rico; M Revilla; E R Hernández; L F Villa; M Alvarez de Buergo
Journal:  Calcif Tissue Int       Date:  1995-03       Impact factor: 4.333

10.  Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group.

Authors:  S R Cummings; D M Black; M C Nevitt; W Browner; J Cauley; K Ensrud; H K Genant; L Palermo; J Scott; T M Vogt
Journal:  Lancet       Date:  1993-01-09       Impact factor: 79.321

View more
  8 in total

Review 1.  Nasal calcitonin.

Authors:  S L Silverman
Journal:  Endocrine       Date:  1997-04       Impact factor: 3.633

Review 2.  Quantitative ultrasound in the assessment of skeletal status.

Authors:  Giuseppe Guglielmi; Judith Adams; Thomas M Link
Journal:  Eur Radiol       Date:  2009-03-04       Impact factor: 5.315

3.  Three-year longitudinal study with quantitative ultrasound at the hand phalanx in a female population.

Authors:  R Mele; G Masci; V Ventura; D de Aloysio; M Bicocchi; R Cadossi
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

Review 4.  The use of ultrasound in the assessment of bone status.

Authors:  S Gonnelli; C Cepollaro
Journal:  J Endocrinol Invest       Date:  2002-04       Impact factor: 4.256

Review 5.  2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada.

Authors:  Jacques P Brown; Robert G Josse
Journal:  CMAJ       Date:  2002-11-12       Impact factor: 8.262

6.  Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.

Authors:  Evangelia Kaskani; G P Lyritis; C Kosmidis; A Galanos; G Andypas; K Chorianopoulos; A Giagiosis; K Iliadou; A Karagianis; K Katsimichas; A Koskinas; K Matsouka
Journal:  Clin Rheumatol       Date:  2005-01-13       Impact factor: 2.980

7.  Quantitative ultrasound of the calcaneus and dual X-ray absorptiometry of the lumbar spine in assessment and follow-up of skeletal status in patients after kidney transplantation.

Authors:  D Kovac; J Lindic; A Kandus; F A Bren
Journal:  Osteoporos Int       Date:  2003-03-18       Impact factor: 4.507

8.  Quantitative ultrasound measurements of bone: measurement error, discordance, and their effects on longitudinal studies.

Authors:  J Zochling; T V Nguyen; L M March; P N Sambrook
Journal:  Osteoporos Int       Date:  2004-02-13       Impact factor: 4.507

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.